TVARDI THERAPEUTICS, INC. Money Market Funds, at Carrying Value
TVARDI THERAPEUTICS, INC. (TVRD) had Money Market Funds, at Carrying Value of $15.10 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:MoneyMarketFundsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Money Market Funds, at Carrying Value $15.10M.
- 2026-03-31: Money Market Funds, at Carrying Value $19.20M.
- 2025-12-31: Money Market Funds, at Carrying Value $20.00M.
- 2025-09-30: Money Market Funds, at Carrying Value $18.70M.
| Period end | Money Market Funds, at Carrying Value |
|---|---|
| 2026-06-30 | $15.10M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $19.20M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $20.00M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $18.70M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $19.60M 10-Q · filed 2025-08-14 |
| 2024-12-31 | $31.30M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |